Diamond Pharma Services acquires PharmaCentral to enhance its pharmacovigilance capabilities and expand its presence in Europe.
Information on the Target
PharmaCentral is a prominent pharmacovigilance services and medical affairs company headquartered in Dublin, Ireland. The firm specializes in delivering comprehensive pharmacovigilance consultancy services, drawing upon extensive experience within the pharmaceutical and Contract Research Organization (CRO) sectors. PharmaCentral's expertise aids in ensuring compliance with safety regulations and enhancing the effectiveness of medical products through diligent monitoring and analysis.
This acquisition by Diamond Pharma Services signifies a strategic move to incorporate PharmaCentral's innovative solutions and specialized knowledge into its existing pharmacovigilance division, Diamond PV Services. By leveraging PharmaCentral's capabilities, Diamond aims to improve its service offerings and expand its expertise to meet the growing demands of a rapidly evolving industry.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in Ireland
The pharmaceutical industry in Ireland is a cornerstone of the nation’s economy, contributing significantly to export revenues and job creation. Renowned for its strong regulatory framework and favorable business environment, Ir
Similar Deals
Diamond Pharma Services
invested in
PharmaCentral
in
in a Other deal